DPP4 and type 2 diabetes mellitus: On the basis of these and other studies, it appears that there is a cross-talk between AGE-RAGE signaling and the DPP-4/incretin system, which may represent a novel therapeutic target for preventing vascular complications of type 2 diabetes [116].